GENE ONLINE|News &
Opinion
Blog

Cancer
Extracting Clinical Information from Cancer Genomics
2021-06-10
New IO Targets and Resistance Mechanisms of Immune Checkpoint-Based Therapies
2021-06-10
ASCO
#ASCO21: Large Cohort Study by Foundation Medicine and Collaborators Reveal Disparities in Precision Cancer Care
2021-06-09
Day 4 ASCO 2021 Roundup: Immunotherapy Candidates Show Promise in Early Studies
2021-06-09
Day 3 ASCO 2021 Roundup: Lynparza, Keytruda and Novartis’ Radioligand Therapy Take Honors in Plenary Session
2021-06-09
Interviews Precision Oncology
The Maturation of Blood-Based Diagnostics to Nip Cancers in the Bud: An Interview with Dr. Jimmy Lin
2021-06-02
Trials & Approvals KRAS
We Have a Winner! Amgen Grabs First FDA Nod in the Race for Undruggable KRAS
2021-05-30
Technology AI
Memorial Sloan Kettering AI spinout Partners with a Fortune 500 Company to Advance AI-powered Cancer Diagnosis
2021-05-28
Ranking & Reports Precision Oncology
10 Precision Oncology Companies to Look Out for
2021-05-27
Technology AI
Exscientia Signs $1 Billion Worth AI Deal to Boost BMS’ Drug Discovery Pipeline
2021-05-21
R&D Cancer Therapy
A Glance at Gene Therapy Advances in Cancer
2021-05-16
Technology Immuno-oncology
ASGCT21 Highlights: Present Trends and Future Directions of Gene and Cell Therapies in Immuno-Oncology
2021-05-14
M&A
CrownBio Acquires Dutch CRO to Expand In Vitro Services Portfolio
2021-05-07
Funding ecDNA
Boundless Bio Raises Fresh Capital to Boost extrachromosomal DNA Targeting Therapeutic Efforts
2021-04-30
Precision Oncology
AstraZeneca, Geneseeq Sign Collaborative Deal to Build Bio Center in China
2021-04-29
1 … 7 8 9 10 11 … 22
LATEST
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top